https://scholars.lib.ntu.edu.tw/handle/123456789/465731
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Lee P.-C. | en_US |
dc.contributor.author | Lin C.-Y. | en_US |
dc.contributor.author | Peng C.-L. | en_US |
dc.contributor.author | MING-JIUM SHIEH | en_US |
dc.creator | Lee P.-C.;Lin C.-Y.;Peng C.-L.;Ming-Jium Shieh | - |
dc.date.accessioned | 2020-02-27T06:39:26Z | - |
dc.date.available | 2020-02-27T06:39:26Z | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 2047-4830 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84997419201&doi=10.1039%2fc6bm00444j&partnerID=40&md5=6ec2ff9be7726739838cd5b34ecb57dd | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/465731 | - |
dc.publisher | Royal Society of Chemistry | - |
dc.relation.ispartof | Biomaterials Science | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.title | Development of a controlled-release drug delivery system by encapsulating oxaliplatin into SPIO/MWNT nanoparticles for effective colon cancer therapy and magnetic resonance imaging | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1039/c6bm00444j | - |
dc.identifier.pmid | 27722406 | - |
dc.identifier.scopus | 2-s2.0-84997419201 | - |
dc.relation.pages | 1742-1753 | - |
dc.relation.journalvolume | 4 | - |
dc.relation.journalissue | 12 | - |
item.openairetype | journal article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
item.grantfulltext | none | - |
crisitem.author.dept | Biomedical Engineering | - |
crisitem.author.dept | Oncology-NTUH | - |
crisitem.author.dept | School of Medicine | - |
crisitem.author.orcid | 0000-0003-2921-4443 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Engineering | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
顯示於: | 醫學工程學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。